MphaR Green Initiative
Earth’s global average temperature in 2021 has been crowned as the sixth warmest on record, according to independent analyses done by NASA and the National Oceanic and Atmospheric Administration (NOAA). Carbon dioxide (CO2) levels and other greenhouse gases in the atmosphere rose around 180 mega tonnes (Mt) above in 2021 as it set its own records against the pre-pandemic period 2019. Moreover, Carbon dioxide emissions rose to 6% increase that gravely affected the global economic output. As a result, climate change is affecting every country on every continent. It is disrupting national economies and affecting lives. Weather patterns are changing, sea levels are rising, and weather events are becoming more extreme.
Pharma Industry and impact on Carbon emission
The Royal Pharmaceutical Society (RPS) formally published a declaration for climate and ecological emergency as it caters to provide a healthy environment for a healthy and safe future. As a result, this society is wholly committed to taking action to tackle the climate and ecological emergency. Alongside that, many other pharmaceutical companies and organizations were invited to attend advisory boards, steering committees, and other successful scientific events. This means if we count with an average 750 km/h flight velocity that makes a total of cca 7 454 tons of CO2 kg of CO2 per year.
Global efforts and commitments to control Global Warming
The UN SG states that 2021 is a “make or break year” to confront the global climate emergency and bring out a change. In BiH, ahead of COP26, the UN is mobilizing support for climate action. Furthermore, the United Kingdom, in partnership with Italy, hosted the 26th UN Climate Change Conference of the Parties (COP26) in Glasgow on 1st – 12th of November 2021.
The COP26 summit will bring parties together to readily accelerate action towards the goals of the Paris Agreement and the UN Framework Convention on Climate Change.
Pharma’s contribution to reducing the Carbon emissions
2020 proved to be the year without extensive travelling. However, it did not affect the business result of any Pharmaceutical Company. However, after the lockdown was lifted, Pharmaceutical Companies were able to exhibit their utmost dedication and skills to save the environment more efficiently in 2021 as the lockdown has been uplifted which ushers a series of more effective ways to serve the climate. Many Global Pharma Companies made the commitment to reduce in the future unnecessary travelling to provide their contribution to the Paris Agreement and the commitment done by the Governments of many countries Worldwide.
MphaR commitment through the project Green Initiative
MphaR is developing different digital platforms to be used by Pharmaceutical Companies to keep the commitment to reduce unnecessary travelling for employees and HCPs. Learn more https://m-phar.com/mphar-digital-solutions/